Given the fact that strictly peripheral CB1R antagonism activates BAT and reduces adiposity in mice, we anticipate that strategies inhibiting CB1R selectively on (brown) adipocytes or reducing endocannabinoid synthesis by adipocytes may be a worthwhile strategy to pursue in combating obesity and associated disorders. The gene discussed is CNR1; the disease is obesity disorder.